SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Vingsbo Carina) srt2:(1996-1999)"

Search: WFRF:(Vingsbo Carina) > (1996-1999)

  • Result 1-5 of 5
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Vingsbo, Carina, et al. (author)
  • Pristance-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by MHC and non-MHC genes
  • 1996
  • In: American Journal of Pathology. - 1525-2191. ; 149:5, s. 1675-1683
  • Journal article (peer-reviewed)abstract
    • We present a novel animal model for rheumatoid arthritis induced with a well defined synthetic adjuvant oil, pristane. Two weeks after a single intradermal injection of 150 microliters of pristane, the rats developed severe and chronic arthritis. The inflammation was restricted to the joints and involved pannus formation, major histocompatibility complex (MHC) class II expression, and T lymphocyte infiltration. The initial development as well as the chronic stage of pristane-induced arthritis was ameliorated by treatment with antibodies to the alpha beta-T-cell receptor showing that the disease is T cell dependent. Increased levels of interleukin in serum was seen after pristane injection but not during the chronic stage of arthritis. Joint erosions were accompanied by elevated serum levels of cartilage oligomeric matrix protein. Comparison of MHC congenic LEW strains showed that the severity and chronicity of arthritis varied among the different MHC haplotypes. Rats with RT1f haplotype showed a significantly higher susceptibility to pristane-induced arthritis. A strong influence of non-MHC genes was also suggested by the variability of arthritis susceptibility among different strains with the same MHC haplotype; the most susceptible background was the DA and the least susceptible was the E3. Arthritis induced with a well defined nonimmunogenic adjuvant, with a disease course that closely resembles that of rheumatoid arthritis, makes a suitable animal model for future studies of the pathology and genetics of rheumatoid arthritis
  •  
3.
  • Vingsbo Lundberg, Carina (author)
  • Chronic Arthritis in Rats; Pathogenesis and genetic factors
  • 1997
  • Doctoral thesis (other academic/artistic)abstract
    • The immune pathology and MHC association of chronic arthritis was studied in three rat models for reumatoid arthritis (RA). Susceptible rat strains develop a T cell dependent chronic disease after immunization with rat collagen type II (CII). The LEW rat does not develop arthritis after immunization with rat CII, but a heterologous immune response to pepsin can break the tolerance to CII and render it susceptible to collagen induced arthritis (CIA). DA rats are protected against CIA if pre-treated with denatured CII or native CII in a non arthritogenic fashion. This was associated with a poor B cell response but a normal T cell response compared to that of CIA, suggesting that B cells specific for conformational epitopes on the CII molecule are essential for the development of chronic CIA. The non-immunogenic adjuvants, avridine and pristane induced chronic T cell dependent arthritis in rats. CIA, AvIA and PIA had a similar MHC association, with RT1a and RT1f being the most susceptible haplotypes. In AvIA and PIA, the MHC mainly influenced the chronicity of arthritis. The genetic control of the PIA model, apart from the MHC association (pia1), was further analyzed in a cross between E3 and DA. A total genome scan of the F2 progeny revealed an additional loci; pia2 on chromosome 12 and two suggestive loci pia3 on chromosome 6 and pia4 on chromosome 11. Pia2 and pia4 were also associated with an a1-acid glycoprotein production and an IgG2b and rheumatoid factor response, whereas pia3 was associated with a fibronectin and IL-6 response.
  •  
4.
  •  
5.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-5 of 5

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view